Glucosamine and Methylsulfonylmethane Tablets
Glucosamine and Methylsulfonylmethane Tablets are prepared from either Glucosamine Hydrochloride, Glucosamine Sulfate Sodium Chloride, Glucosamine Sulfate Potassium Chloride, or a mixture of any of them, with Methylsulfonylmethane. Tablets contain NLT 90.0% and NMT 120.0% of the labeled amount of glucosamine (C6H13NO5) and NLT 90.0% and NMT 110.0% of the labeled amount of methylsulfonylmethane (C2H6O2S).
• A. Presence of Glucosamine: The retention times of the major peaks of the Sample solution correspond to those of the Standard solution, as obtained in the Content of Glucosamine.
• B. Presence of Methylsulfonylmethane: The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Content of Methylsulfonylmethane.
• Content of Glucosamine
Diluent: Transfer 29 µL of acetic acid and 5 mL of acetonitrile to a 100-mL volumetric flask containing 50 mL of water, and dilute with water to volume.
Borate buffer: 0.2 M (76.3 g/L of sodium borate in water) adjusted with hydrochloric acid TS to a pH of 9.5. [NoteBuffer must be stored at room temperature. It must be warmed to dissolve if crystallization occurs. ]
Acetate buffer: 6.80 g/L of sodium acetate trihydrate in water adjusted with dilute acetic acid to a pH of 5.9
Derivatizing reagent: In a 14-mL polypropylene culture tube dissolve 50 mg of o-phthalaldehyde in 1.25 mL of anhydrous methanol. Add 50 µL of 3-mercaptopropionic acid and 11.2 mL of Borate buffer, and mix gently. Allow to stand in the dark for 30 min before use. [NoteReagent strength is maintained by adding 10 µL of 3-mercaptopropionic acid every 2 days. Storage should be in the dark, at room temperature, and can be used for NMT 2 weeks. ]
Mobile phase: Methanol and Acetate buffer (1:9)
Standard solution: 1.0 mg/mL of USP Glucosamine Hydrochloride RS in water. Allow to stand at room temperature for 1 h.
Sample solution: Transfer an equivalent to 25 mg of glucosamine from NLT 20 Tablets, finely powdered, to a 25-mL volumetric flask, and dilute with Diluent to volume. Mix on a vortex mixer to suspend the powder in solution. Sonicate in a 65 water bath for 20 min. Remove from the bath, stir for 5 min with the aid of a magnetic stirrer, and centrifuge.
Detector: UV 340 nm
Column: 3.0-mm × 5-cm; packing L1
Flow rate: 1 mL/min
Injection size: 10 µL
Samples: Five individual aliquots of the Standard solution derivatized as directed for Analysis. Each derivatized aliquot is injected only once.
[NoteThe relative retention times for the -anomer and the -anomer are 1.0 and 1.8, respectively. The retention time for the -anomer is NLT 4 min. ]
Relative standard deviation: NMT 2.0% for five replicate injections
Samples: Standard solution and Sample solution
Transfer 100 µL of the Derivatizing reagent and 100 µL of the Standard solution or the Sample solution to a vial containing 400 µL of Borate buffer. Allow the derivatization to proceed for 1 min. Inject the derivatized solutions immediately after the derivatization reaction.
Calculate the percentage of the labeled amount of glucosamine (C6H13NO5) in the portion of Tablets taken:
Result = (rU/rS) × (CS/CU) × (Mr1/Mr2) × 100
Acceptance criteria: 90.0%120.0% of the labeled claim
• Content of Methylsulfonylmethane
Diluent: Transfer 950 mL of methanol to a 1-L volumetric flask. Add 0.60 mL of diethylene glycol methyl ether, and dilute with methanol to volume.
Standard solution: 0.4 mg/mL of USP Methylsulfonylmethane RS in Diluent. Sonicate at 50 for 1 min, and allow to cool to room temperature.
Sample solution: Finely powder NLT 20 Tablets. Dissolve a portion of the finely powdered material, equivalent to 1 Tablet, in Diluent, and sonicate for 15 min at 50. Allow to cool to room temperature, dilute with Diluent to volume, and mix. Quantitatively dilute with Diluent to obtain a final concentration of 0.4 mg/mL of methylsulfonylmethane. Transfer 1 mL of the suspension to a 1.5-mL microcentrifuge tube, and centrifuge for 20 s. Use the supernatant.
Detector: Flame ionization
Column: 0.53-mm × 30-m capillary; 5-µm phase G2 coating
Carrier gas: Helium
Flow rate: 5 mL/min
Injection size: 1 µL
Injector type: Split ratio, 2:1
Sample: Standard solution
Relative standard deviation: NMT 2.0% for the peak response ratio of methylsulfonylmethane to diethylene glycol methyl ether from replicate injections
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of methylsulfonylmethane (C2H6O2S) in the portion of Tablets taken:
Result = (RU/RS) × (CS/CU) × 100
Acceptance criteria: 90.0%110.0% of the label claim
• Disintegration and Dissolution 2040: Meet the requirements for Dissolution
Medium: Water; 900 mL
Apparatus 2: 75 rpm
Time: 60 min
Determine the percentage of glucosamine dissolved as follows.
Standard solution: Prepare as directed in the test for Content of Glucosamine. Dilute with a suitable quantity of water, if necessary.
Sample solution: Use the solution under test.
Borate buffer, Acetate buffer, Derivatizing reagent, Mobile phase, Chromatographic system, and Analysis: Proceed as directed in the test for Content of Glucosamine.
Calculate the percentage of the labeled amount of glucosamine (C6H13NO5) dissolved:
Result = (rU/rS) × (CS × V/L) × (Mr1/Mr2) × 100
Tolerances: NLT 75% of the labeled amount of glucosamine (C6H13NO5) is dissolved.
• Weight Variation 2091: Meet the requirements
• Packaging and Storage: Preserve in tight, light-resistant containers.
• Labeling: The label indicates the types of glucosamine salts contained in the article.
• USP Reference Standards 11
USP Methylsulfonylmethane RS
Auxiliary Information Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 1338Pharmacopeial Forum: Volume No. 32(4) Page 1137